BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1275477)

  • 1. [Blood coagulation system in oncological patients treated with rubomycin, adriamycin and carminomycin].
    Zhukovskaia ES; Gorbunova VA; Khvatova NV
    Antibiotiki; 1976 Mar; 21(3):273-7. PubMed ID: 1275477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative experimental study of the antileukemia activity of carminomycin and rubomycin].
    Khanykova OK; Vinogorova GF
    Antibiotiki; 1977 Sep; 22(9):846-52. PubMed ID: 911158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative evaluation of the results of mono- and polychemotherapy of disseminated forms of breast cancer using the CMFVP program and anthracycline antibiotics (carminomycin and adriamycin)].
    Trishkina EA; Gershanovich ML; Pavlov KA; Danova LA; Labkovskiĭ BM
    Antibiotiki; 1983 Nov; 28(11):853-8. PubMed ID: 6689116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of carminomycin on children and adolescents with osteogenic sarcoma].
    Bizer VA
    Antibiotiki; 1979 Feb; 24(2):137-40. PubMed ID: 373620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [First phase in the clinical study of the antineoplastic antibiotic, carminomycin].
    Perevodchikova NI; Gorbunova VA; Lichinitser MR; Borisov VI; Alekseev NA
    Antibiotiki; 1975 Sep; (9):853-6. PubMed ID: 1101812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in thrombocytes under adriamycin therapy].
    Ruzicka F; Böhnel J; Fierkens B; Grohs H; Stacher A
    Int Z Klin Pharmakol Ther Toxikol; 1971 Dec; 5(3):345-51. PubMed ID: 5148891
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative study of the cardiotoxicity of the anthracycline antibiotics, rubomycin, carminomycin and dihydrocarminomycin, in experiments on white mice].
    Shepelevtseva NG; Belova IP; Vertogradova TP; Gol'dberg LE
    Antibiotiki; 1978 Jan; 23(1):78-87. PubMed ID: 623453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Possibilities of preventing cardiotoxic complications in chemotherapy with carminomycin].
    Labkovskiĭ BM; Danova LA; Gershanovich ML; Kondrat'ev VB
    Antibiotiki; 1978 Sep; 23(9):851-4. PubMed ID: 358915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experience with using carminomycin in oncological clinical practice].
    Gorbunova VA
    Antibiot Khimioter; 1992 Mar; 37(3):35-9. PubMed ID: 1325145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum enzymatic activity in oncological patients treated with carminomycin].
    Gar'kavyĭ MI; Kovner FIa
    Antibiotiki; 1978 Aug; 23(8):756-60. PubMed ID: 210711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic use of carminomycin in soft tissue sarcomas].
    Perevodchikova NI; Gorbunova VA; Lichinitser MR; Moroz LV
    Antibiotiki; 1976 Jul; 21(7):657-60. PubMed ID: 782353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Carminomycin induction of single-stranded breaks in the DNA of tumor cells].
    Trenin AS
    Antibiotiki; 1978 May; 23(5):400-3. PubMed ID: 655684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preliminary results of a cooperative clinical study of the new antitumor antibiotic, carminomycin].
    Borisov VI; Lipatov AM; Perevodchikova NI; Alekseev NA; Vygovskaia IaI
    Antibiotiki; 1976 Nov; 21(11):1026-30. PubMed ID: 798543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of microbial and tumor cell adaptation to rubomycin on their uptake of rubomycin and carminomycin].
    Ostanina LN; Averbukh LA; Karpov VL; Dudnik IuV; Liashenko VA
    Antibiotiki; 1978 Sep; 23(9):837-40. PubMed ID: 697342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Carminomycin in drug combination in breast cancer and soft tissue sarcomas].
    Lichinitser MR; Assekritova IV; Gorbunova VA
    Antibiotiki; 1977 Oct; 22(10):940-3. PubMed ID: 411416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Action of carminomycin on leukemic cell proliferation and some problems of its use in the combined therapy of leukemias].
    Egorov LV; Khanykova OK; Kuznetsova TV; Rudneva NA; Kozinets GI
    Antibiotiki; 1978 Sep; 23(9):833-6. PubMed ID: 697341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Liver mono-oxygenases and the pharmacodynamics of carminomycin and rubomycin].
    Bogush TA; Sitdikova SM
    Antibiotiki; 1984 Jun; 29(6):446-50. PubMed ID: 6476808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of the antitumor activity of carminomycin in malignant tumors in children (a preliminary report)].
    Durnov LA; Susuleva NA; Lichinitser MR
    Antibiotiki; 1976 Jul; 21(7):654-7. PubMed ID: 782352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic performance of carminomycin-cyclophosphamide against L1210 leukemia.
    Avery TL; Cruze PG
    Cancer Res; 1978 Sep; 38(9):2892-5. PubMed ID: 679196
    [No Abstract]   [Full Text] [Related]  

  • 20. [Influence of cytostatic combination therapy with vincristine sulphate and iphosphamide on blood coagulation].
    Neidhardt B; Hartwich G
    Dtsch Med Wochenschr; 1975 Feb; 100(9):409-12. PubMed ID: 1116466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.